The repertoire of iron superoxide dismutases from <i>Leishmania infantum</i> as targets in the search for therapeutic agents against leishmaniasis-Reference-Cited by-同舟云学术

The repertoire of iron superoxide dismutases from Leishmania infantum as targets in the search for therapeutic agents against leishmaniasis

Published:2024-07-22 Issue:1 Volume:39 Page:
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

García-Soriano Juan Carlos¹,de Lucio Héctor¹,Elvira-Blázquez Daniel¹,Alcón-Calderón Mercedes¹,Sanz del Olmo Natalia²³,Sánchez-Murcia Pedro A.⁴,Ortega Paula²³,de la Mata Francisco Javier²³,Jiménez-Ruiz Antonio¹

Affiliation:

1. Departamento de Biología de Sistemas, Universidad de Alcalá, Alcalá de Henares, Spain

2. Departamento de Química Orgánica y Química Inorgánica, Universidad de Alcalá, Instituto de Química Andrés Manuel del Río, Alcalá de Henares, Spain

3. Instituto de Investigación Sanitaria Ramón y Cajal, IRYCIS, Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina, CIBER-BBN, Madrid, Spain

4. Division of Medicinal Chemistry, Laboratory of Computer-Aided Molecular Design, Otto-Loewi Research Center, Medical University of Graz, Graz, Austria

Funder

Spanish MICINN

Comunidad de Madrid

Universidad de Alcalá

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14756366.2024.2377586

Reference52 articles.

1. Leishmaniasis World Health Organization [cited 2023 Oct 31]; 2023. Available from: https://www.who.int/news-room/fact-sheets/detail/leishmaniasis

2. Advances in the treatment of Chagas disease: Promising new drugs, plants and targets

3. Antileishmanial Drug Discovery and Development: Time to Reset the Model?

4. Access and utilization of host-derived iron by Leishmania parasites;Goto Y;J Biochem,2023

5. Overoxidation and oligomerization of Trypanosoma cruzi cytosolic and mitochondrial peroxiredoxins;Piñeyro MD;Pathogens,2023